Loading company…
Neo Binder uses AI to design functional proteins and provide related technologies and services.
Founded in 2022, Neo Binder is based in Beijing, China, and develops AI-designed proteins, technology platforms, and related services. Its work covers bio-based materials, cell therapy, and medical care services. The company uses generative AI algorithms to modify strain properties such as catalytic efficiency, conversion rate, and thermal stability. In June 2023, it raised angel funding from Unity Ventures.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign in